tradingkey.logo
tradingkey.logo
Search

Baxter International Inc

BAX
Add to Watchlist
17.990USD
+0.510+2.92%
Close 05/08, 16:00ETQuotes delayed by 15 min
9.29BMarket Cap
LossP/E TTM

Baxter International Inc

17.990
+0.510+2.92%
View Detailed Chart
Intraday
1m
30m
1h
D
W
M
D

Today

+2.92%

5 Days

+4.53%

1 Month

+3.99%

6 Months

-0.06%

Year to Date

-5.86%

1 Year

-41.78%

Key Insights

Baxter International Inc's fundamentals are relatively stable, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 58 out of 206 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 21.46.In the medium term, the stock price is expected to trend down.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Baxter International Inc's Score

Industry at a Glance

Industry Ranking
58 / 206
Overall Ranking
147 / 4494
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Negative

Baxter International Inc Highlights

StrengthsRisks
Baxter International Inc. is a global medtech company. Its segments include Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. The Medical Products and Therapies segment includes sales of its sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies and surgical hemostat, sealant, and adhesion prevention products. The Healthcare Systems and Technologies segment includes sales of its connected care solutions and collaboration tools, including smart bed systems, patient monitoring systems and diagnostic technologies, respiratory health devices, and advanced equipment for the surgical space, including operating room integration technologies, precision positioning devices, and other accessories. The Pharmaceuticals segment includes sales of specialty injectable pharmaceuticals, inhaled anesthesia, and drug compounding. It provides a portfolio of diagnostic, critical care, nutrition, hospital and surgical products.
Fairly Valued
The company’s latest PE is -8.40, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 567.26M shares, decreasing 4.87% quarter-over-quarter.
Held by Scotia Canadian Dividend Fund
Star Investor Scotia Canadian Dividend Fund holds 83.06K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.67.

Analyst Rating

Based on 18 analysts
Hold
Current Rating
21.455
Target Price
+22.67%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Baxter International Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Baxter International Inc Info

Baxter International Inc. is a global medtech company. Its segments include Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. The Medical Products and Therapies segment includes sales of its sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies and surgical hemostat, sealant, and adhesion prevention products. The Healthcare Systems and Technologies segment includes sales of its connected care solutions and collaboration tools, including smart bed systems, patient monitoring systems and diagnostic technologies, respiratory health devices, and advanced equipment for the surgical space, including operating room integration technologies, precision positioning devices, and other accessories. The Pharmaceuticals segment includes sales of specialty injectable pharmaceuticals, inhaled anesthesia, and drug compounding. It provides a portfolio of diagnostic, critical care, nutrition, hospital and surgical products.
Ticker SymbolBAX
CompanyBaxter International Inc
CEOHider (Andrew P)
Websitehttps://www.baxter.com/
KeyAI